RHO GTPases activate CIT
REACTOME PATHWAYThe RHO GTPases activate CIT pathway (Reactome ID: R-HSA-5625900) involves 2 genes and is affected by 4 compounds in the BiohacksAI evidence corpus. Compound-pathway associations are derived from target overlap: a compound is linked to this pathway if it targets ≥2 genes within the pathway.
Genes in this Pathway
Compounds Affecting RHO GTPases activate CIT
| # | Compound | Targets Hit | Studies |
|---|---|---|---|
| 1 | Sorafenib | — | 300 |
| 2 | Afatinib | — | 297 |
| 3 | hydroxyfasudil [Supplementary Concept] | — | 11 |
| 4 | Atorvastatin | — | 1,000 |
About the RHO GTPases activate CIT Pathway
The RHO GTPases activate CIT pathway is catalogued in Reactome (ID: R-HSA-5625900) and involves 2 genes. In the BiohacksAI corpus, 4 compounds have documented interactions with at least 2 genes in this pathway, establishing mechanistic relevance. Key pathway genes include CIT, RHOC.